These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11377488)

  • 1. Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil.
    Jain S; Metcalfe M; White SA; Furness PN; Nicholson ML
    Transplant Proc; 2001 May; 33(3):2165-6. PubMed ID: 11377488
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil prevents the progression of chronic kidney allograft nephropathy.
    Park JH; Park JH; Yang CW; Kim YS; Kim SY; Moon IS; Koh YB; Bang BK
    Transplant Proc; 2000 Nov; 32(7):1747. PubMed ID: 11119917
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil and reduction in cyclosporine dosage for chronic renal allograft dysfunction.
    Islam MS; Francos GC; Dunn SR; Burke JF
    Transplant Proc; 1998 Aug; 30(5):2230-1. PubMed ID: 9723452
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic allograft nephropathy: prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution.
    McGrath JS; Shehata M
    Transplant Proc; 2001 May; 33(3):2193-5. PubMed ID: 11377500
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic allograft nephropathy: effect of cyclosporine reduction and addition of mycophenolate mofetil on progression of renal disease.
    Weir MR; Fink JC; Hanes DS; Gardner J; Klassen DK; Cangro C; Schweitzer E; Bartlett ST
    Transplant Proc; 1999; 31(1-2):1286-7. PubMed ID: 10083574
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolate mofetil conversion or addition in patients with chronic progressive deterioration of renal allograft function.
    Altaca G; Berber I; Aydin C; Yigit B; Aydin M; Titiz I
    Transplant Proc; 2001; 33(7-8):3248-9. PubMed ID: 11750391
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group.
    Transplant Proc; 1997; 29(1-2):348-9. PubMed ID: 9123033
    [No Abstract]   [Full Text] [Related]  

  • 8. Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation.
    Weir MR
    Transplant Proc; 2001 Jun; 33(4 Suppl):19S-28S. PubMed ID: 11406264
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction.
    Senn B; Rochat P; Schwarzkopf AK; Weinreich T; Binswanger U
    Transplant Proc; 1998 Dec; 30(8):4075-6. PubMed ID: 9865301
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients.
    Tsang WK; Tong KL; Yeung S; Lee W; Chan HW
    Transplant Proc; 2000 Nov; 32(7):1755-6. PubMed ID: 11119921
    [No Abstract]   [Full Text] [Related]  

  • 11. Triple therapy with mycophenolate mofetil versus azathioprine.
    Muñiz ML; Amenabar J; Gómez-Ullate P; Urbizu J; Lampreabe I
    Transplant Proc; 1999; 31(1-2):1144-6. PubMed ID: 10083512
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience.
    Jirasiritham S; Sumethkul V; Mavichak V; Jirasiritham S; Chiewsilp P; Leenanupunth C; Kochakarn W
    Transplant Proc; 1998 Nov; 30(7):3576-7. PubMed ID: 9838566
    [No Abstract]   [Full Text] [Related]  

  • 13. Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function.
    Fritsche L; Sperschneider H; Budde K; Giessing M; Türk H; Böhler T; Schröder K; Stein G; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):2229. PubMed ID: 9723451
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy.
    Gonzalez Molina M; Seron D; Garcia del Moral R; Carrera M; Sola E; Jesus Alferez M; Gomez Ullate P; Capdevila L; Gentil MA
    Transplantation; 2004 Jan; 77(2):215-20. PubMed ID: 14742984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.
    Taheri M; Pourmand G; Mehrsai AR; Mansoori D
    Transplant Proc; 2003 Nov; 35(7):2752-3. PubMed ID: 14612105
    [No Abstract]   [Full Text] [Related]  

  • 16. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.
    Smak Gregoor PJ; Hesse CJ; van Gelder T; van der Mast BJ; IJzermans JN; van Besouw NM; Weimar W
    Transplant Proc; 1998 Jun; 30(4):1192-3. PubMed ID: 9636482
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of chronic renal allograft failure by addition of mycophenolate mofetil: single-center experience in 40 patients.
    Kliem V; Boeck A; Eisenberger U; Petersen R; Radermacher J; Hiss M; Pethig M; Koch KM; Nashan B; Brunkhorst R
    Transplant Proc; 1999; 31(1-2):1312-3. PubMed ID: 10083586
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of mycophenolate mofetil in combination with standard immunosuppression on chronic transplant nephropathy: 1 year experience.
    Khachatryan N; Wauters JP; Vogel G
    Transplant Proc; 2002 May; 34(3):807-8. PubMed ID: 12034190
    [No Abstract]   [Full Text] [Related]  

  • 19. A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion.
    Thervet E; Morelon E; Ducloux D; Bererhi L; Noël LH; Janin A; Bedrossian J; Puget S; Chalopin JM; Mihatsch M; Legendre C; Kreis H
    Transplant Proc; 2000 Dec; 32(8):2778. PubMed ID: 11134800
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of mycophenolate mofetil in renal transplant patients with cyclosporin toxicity.
    Shaheen FA; Sheikh IA
    Transplant Proc; 1999 Dec; 31(8):3294. PubMed ID: 10616481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.